Psoralen plus ultraviolet A (PUVA) in the treatment of chronic graft versus host disease: preliminary experience in standard treatment resistant patients

Semin Hematol. 1992 Apr;29(2):108-12.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Chronic Disease
  • Drug Resistance / radiation effects
  • Female
  • Ficusin / therapeutic use*
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Male
  • PUVA Therapy*

Substances

  • Ficusin